Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Beaudart C, Malréchauffé Y, van Heden S, et al.
Drugs, 2026
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis
Milluzzo A, Oteri V, Manuella L, et al.
International journal of obesity (2005), 2026
Body Composition and Lifestyle Interventions in Pharmacological Treatment of Acquired Hypothalamic Obesity: A Systematic Review of Randomized Controlled Trials
Yu H, Wang J, Yin M, et al.
Obesity (Silver Spring, Md.);34(9):1687-1698
Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes
Olubodun T, Osundina MA, Soyoye DO, et al.
PloS one, 2026;21(8):e0354497
Is There a Better Day of the Week to Administer Semaglutide or Tirzepatide? A Systematic Literature Review
La Vignera S, Condorelli RA
Medicina (Kaunas, Lithuania), 2026;62(8)
Peripheral nerve complications from medications utilised for weight loss: a systematic review
O'Gorman C, O'Gorman M, Warren N
Journal of neurology, 2026;273(8)
GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks
Roca Mora MM, Sanchez-Monge M, Balardini Ayoub D, et al.
Frontiers in psychiatry, 2026;17:1857078
Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists
Khatami S, Faghihi M, Tavakoli G, et al.
Cardiovascular toxicology, 2026;26(7)
Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis
Kishi T, Ikuta T, Sakuma K, et al.
Translational psychiatry, 2026
Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis
Yang Q, Hassan W, Ahmed H, et al.
BMC ophthalmology, 2026
Long-Term Safety and Renal Outcomes of Semaglutide in Non-Diabetic Obesity with Chronic Kidney Disease or Hypertension: A Systematic Review and Meta-Analysis
Elganyny MKE, Elganyni AKE, Maskji HA, et al.
La Clinica terapeutica;177(4):877-886
Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs)
Laverde LP, Muñoz-Velandia OM, Alfonso D, et al.
International journal of obesity (2005), 2026
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials
Wu X, Yang Y, Cui X, et al.
Frontiers in pharmacology, 2026;17:1846714
Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies
Anatriello A, Liguori V, Cagnotta C, et al.
Frontiers in pharmacology, 2026;17:1808359
A systematic review of semaglutide-associated kidney injury case reports
Xiu X, Zheng PP, Li Y, et al.
Frontiers in medicine, 2026;13:1793349